---
title: Creative Enzymes vs WuXi Vaccines
slug_a: creative-enzymes
slug_b: wuxivaccines
site: cdmo
review_signal_gate: closed
canonical_path: /compare/creative-enzymes/wuxivaccines
---

# Creative Enzymes vs WuXi Vaccines

Side-by-side profile data from each company listing on this directory.

## Creative Enzymes

- Profile: [/companies/creative-enzymes](/companies/creative-enzymes)

Creative Enzymes — Creative Enzymes is a global provider of high-quality enzyme products and custom enzyme-related solutions for research, diagnostics, and industrial applications.

Services: 7. Modalities: 2. Indications: 2. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Bioanalysis
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Translational Research
- Recombinant Protein Manufacturing
- Microbial Fermentation
- CMC Analytical Development

### Modalities

- Biologics (Other)
- mRNA

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Expression: Microbial

## WuXi Vaccines

- Profile: [/companies/wuxivaccines](/companies/wuxivaccines)

WuXi Vaccines — Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.

Services: 11. Modalities: 4. Indications: 1. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vaccine Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector